Q1 2025 Management View CEO Joe Papa highlighted significant progress in Emergent's multiyear turnaround plan, focusing on stabilizing operations, streamlining costs, and driving sustainable growth.

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Bavarian Nordic’s Vimkunya (recombinant, adsorbed ...

A new analysis of existing literature in Annals of Internal Medicine suggests patients prescribed antivirals for nonsevere ...

The freeze-dried formulation will be easier to store and transport than the liquid-frozen formulation that Bavarian Nordic ...

An aide to U.S. Health Secretary Robert F. Kennedy Jr. is seeking more information about three vaccines recommended by a ...

The options are for the freeze-dried version of Bavarian Nordic’s Jynneos, a formulation that allows easier stockpiling.

Bavarian Nordic has supplied a liquid-frozen formulation of JYNNEOS to the U.S. government for stockpiling since 2010 and in ...

Copenhagen, Denmark Saturday, May 3, 2025, 12:00 Hrs [IST] ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation to Bavarian Nordic's ...

The Medicines and Healthcare products Regulatory Agency (MHRA) yesterday approved Vimkunya, a vaccine used to prevent disease caused by the chikungunya virus in people 12 years of age and older. The ...

Bavarian Nordic A/S (OMX: BAVA) announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization in the ...